Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …

Abnormal aggregates of the synaptic protein, α-synuclein, are the dominant pathology in
syndromes known as the synucleinopathies. The cellular aggregation of the protein occurs …

Objective: To determine ways to improve diagnostic accuracy of multiple system atrophy
(MSA), we assessed the diagnostic process in patients who came to autopsy with …

Background: A consensus conference on multiple system atrophy (MSA) in 1998
established criteria for diagnosis that have been accepted widely. Since then, clinical …

Background Multiple system atrophy (MSA) is a fatal and still poorly understood
degenerative movement disorder that is characterised by autonomic failure, cerebellar …

Background Multiple system atrophy is a rare, fatal neurodegenerative disorder with
symptoms of autonomic failure plus parkinsonism, cerebellar ataxia, or both. We report …

Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of
medical conditions. Over the past decade, there has been considerable excitement about …

Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative
disorder that presents with autonomic failure in combination with parkinsonism or cerebellar …

This article reports the severity and profile of neuropsychological impairment on a prevalent
cohort of patients with a clinical diagnosis of either multiple system atrophy (n= 372) or …

Multiple system atrophy (MSA) is a Parkinson's Disease (PD)‐like α‐synucleinopathy
clinically characterized by dysautonomia, parkinsonism, cerebellar ataxia, and pyramidal …